Corrigendum to "Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies": [Immuno-Oncology and Technology 10 (2023) 100394]

Immunooncol Technol. 2023 Oct 17:20:100410. doi: 10.1016/j.iotech.2023.100410. eCollection 2023 Dec.

Abstract

[This corrects the article DOI: 10.1016/j.iotech.2023.100394.].

Publication types

  • Published Erratum